Company Valuation: MedCap AB

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025 2026 2027 2028
Market Cap 1 4,997 8,899 8,278 8,514 - -
Change - 78.07% -6.99% 2.85% - -
Enterprise Value (EV) 1 4,997 9,176 8,359 8,597 8,359 8,118
Change - 83.61% -8.9% 2.84% -2.77% -2.88%
P/E 29.1x 42.9x - 33.5x 28.5x 25.1x
PBR - 6.95x - 4.96x 4.22x 3.62x
PEG - 2.1x - - 1.6x 1.9x
Capitalization / Revenue - 4.93x 3.93x 3.55x 3.17x 2.91x
EV / Revenue - 5.08x 3.97x 3.58x 3.11x 2.77x
EV / EBITDA - 23.7x 18.3x 15.6x 13.2x 11.7x
EV / EBIT - 33.7x 27.6x 23.2x 19.1x 16.9x
EV / FCF - 28.8x 26.4x 46.5x 23.3x 19.7x
FCF Yield - 3.47% 3.79% 2.15% 4.29% 5.07%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 11.6 14 - 16.97 19.95 22.62
Distribution rate - - - - - -
Net sales 1 - 1,807 2,108 2,398 2,686 2,927
EBITDA 1 - 387.7 456.3 551.5 632 694
EBIT 1 - 272.3 302.9 370 437 479.5
Net income 1 172.2 207.4 219.8 258 319 356
Net Debt 1 - 276.5 81.3 83 -155 -395.5
Reference price 2 337.50 601.00 549.00 568.50 568.50 568.50
Nbr of stocks (in thousands) 14,807 14,807 15,078 14,976 - -
Announcement Date 31/01/24 31/01/25 05/02/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- 3.58x15.59x - 888M
31.12x12.25x20.38x1.65% 41.37B
17.28x9.23x14.75x6.1% 23.92B
19.39x8.74x14.23x3.41% 17.9B
24.72x4.82x8.39x3.05% 3.86B
8.02x0.94x5.11x4.67% 1.31B
14.61x13.22x13.61x4.86% 956M
8.51x7.75x8.33x6.32% 786M
7.17x7.2x26.03x4.78% 591M
Average 16.35x 7.53x 14.05x 4.36% 10.17B
Weighted average by Cap. 24.02x 10.15x 16.80x 3.37%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA